Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12619000081112
ACTRN12619000081112
Completed
未知

The impact of trans-jugular intrahepatic portosystemic shunts on body composition in decompensated cirrhosis: A prospective cohort study

Department of Gastroenterology and Hepatology, Austin Health0 sites14 target enrollmentJanuary 21, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionscirrhosisportal hypertensionsarcopeniaTrans-jugular intrahepatic portosystemic shuntOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disorders

Overview

Phase
未知
Intervention
Not specified
Conditions
cirrhosis
Sponsor
Department of Gastroenterology and Hepatology, Austin Health
Enrollment
14
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 21, 2019
End Date
April 18, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Department of Gastroenterology and Hepatology, Austin Health

Eligibility Criteria

Inclusion Criteria

  • •Adult patients \> 18 years old with a diagnosis of cirrhosis on biochemical, clinical, histological or radiological criteria
  • •Referred for TIPS for treatment of complications of portal hypertension
  • •Patients who have had a CT abdomen (including the L3 vertebrae) performed 6 weeks prior or within 48 hours of TIPS procedure

Exclusion Criteria

  • •TIPS for in patients without confirmed cirrhosis
  • •Patients unable to perform physical assessments (including handgrip strength) at the time of TIPS procedure due to reduced conscious state or intubation in intensive care.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Influence of the transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients on sarcopeniaMuscle wasting and atrophy, not elsewhere classified, multiple sitesM62.59K74.6Other and unspecified cirrhosis of liver
DRKS00024507niversitätsklinikum Freiburg100
Withdrawn
Not Applicable
The effects of Transjugular Intrahepatic Portosystemic Shunt placement on von Willebrand factor levels in plasma of patients with cirrhosis and portal hypertension.
NL-OMON38711niversitair Medisch Centrum Groningen16
Not yet recruiting
Not Applicable
Transjugular intrahepatic portosystemic shunt insertion in hepatic patients on the haemodynamics
PACTR201807337809744ational Liver Institute40
Completed
Not Applicable
Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary SyndromeHepatopulmonary Syndrome
NCT02148536West China Hospital64
Unknown
Not Applicable
Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic PatientsCirrhosisAcquired Portal-systemic Shunt Due to CirrhosisHepatic Encephalopathy
NCT02427906West China Hospital50